drugset / Trial / NCT00070642
CPG 7909 Injection in Melanoma
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine the safety, tolerability and effects of CPG 7909 (the study drug) when given with chemotherapy to patients with melanoma.
Timeline
- Start
- 2003-12
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dacarbazine | Small molecule | 850 mg/m2 | — |
| Subject | agatolimod | Oligonucleotide (other) | 10 mg | Subcutaneous |
| Subject | agatolimod | Oligonucleotide (other) | 40 mg | Subcutaneous |